<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">20900</id>
  <title nil="true"/>
  <common-name>Mivacurium</common-name>
  <description>Mivacurium is an organic compound with the chemical formula C58H80N2O14. Mivacurium belongs to the benzylisoquinolines, a subclass of isoquinolines and derivatives within the organic compounds. With an average molecular weight of 1,029 g/mol, Mivacurium is a heavy molecule.

This compound is recorded as a muscle relaxant used in healthcare, pharmaceuticals, and veterinary products, with intravenous administration as the recorded exposure route. Mivacurium interacts with four protein targets: it acts as a partial agonist of the neuronal acetylcholine receptor subunit alpha-2 (CHRNA2), the muscarinic acetylcholine receptor M2 (CHRM2), and the muscarinic acetylcholine receptor M3 (CHRM3). Additionally, it serves as an antagonist/antagonist of cholinesterase (BCHE).</description>
  <cas>133814-19-4</cas>
  <pubchem-id>5281042</pubchem-id>
  <chemical-formula>C58H80N2O14</chemical-formula>
  <weight>1029.3</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2016-05-22T06:30:16Z</created-at>
  <updated-at type="dateTime">2026-08-22T19:38:54Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id>DB01226</drugbank-id>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>COC1=CC(C[C@@H]2C3=CC(OC)=C(OC)C=C3CC[N+]2(C)CCCOC(=O)CC\C=C\CCC(=O)OCCC[N+]2(C)CCC3=CC(OC)=C(OC)C=C3[C@H]2CC2=CC(OC)=C(OC)C(OC)=C2)=CC(OC)=C1OC</moldb-smiles>
  <moldb-formula>C58H80N2O14</moldb-formula>
  <moldb-inchi>InChI=1S/C58H80N2O14/c1-59(25-21-41-35-47(63-3)49(65-5)37-43(41)45(59)29-39-31-51(67-7)57(71-11)52(32-39)68-8)23-17-27-73-55(61)19-15-13-14-16-20-56(62)74-28-18-24-60(2)26-22-42-36-48(64-4)50(66-6)38-44(42)46(60)30-40-33-53(69-9)58(72-12)54(34-40)70-10/h13-14,31-38,45-46H,15-30H2,1-12H3/q+2/b14-13+/t45-,46-,59?,60?/m1/s1</moldb-inchi>
  <moldb-inchikey>ILVYCEVXHALBSC-OTBYEXOQSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">1029.2608</moldb-average-mass>
  <moldb-mono-mass type="decimal">1028.560955278</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp>-0.76</logp>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id>4444509</chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM019795</chemdb-id>
  <dsstox-id>DTXSID6048333</dsstox-id>
  <toxcast-id>48333</toxcast-id>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id>NS00007657</susdat-id>
  <iupac>(1R)-2-(3-{[(4E)-8-{3-[(1R)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinolin-2-ium-2-yl]propoxy}-8-oxooct-4-enoyl]oxy}propyl)-6,7-dimethoxy-2-methyl-1-[(3,4,5-trimethoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinolin-2-ium</iupac>
  <moldb-polar-surface-area>144.90000000000003</moldb-polar-surface-area>
  <moldb-refractivity>308.7439999999999</moldb-refractivity>
  <moldb-polarizability>116.68258620365387</moldb-polarizability>
  <moldb-rotatable-bond-count>30</moldb-rotatable-bond-count>
  <moldb-acceptor-count>12</moldb-acceptor-count>
  <moldb-donor-count>0</moldb-donor-count>
  <moldb-pka-strongest-acidic>18.588257157993706</moldb-pka-strongest-acidic>
  <moldb-pka-strongest-basic>-4.119794035665876</moldb-pka-strongest-basic>
  <moldb-physiological-charge>2</moldb-physiological-charge>
  <moldb-number-of-rings>6</moldb-number-of-rings>
  <moldb-alogps-logp>3.80</moldb-alogps-logp>
  <moldb-alogps-logs>-7.53</moldb-alogps-logs>
  <moldb-alogps-solubility>3.26e-05 g/l</moldb-alogps-solubility>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Isoquinolines and derivatives</klass>
  <subklass>Benzylisoquinolines</subklass>
  <paper-count type="integer">827</paper-count>
  <sync-id>CED0008638</sync-id>
  <structure-inchikey>ILVYCEVXHALBSC-OTBYEXOQSA-N</structure-inchikey>
  <structure-fingerprint>400000000000000008000000000000000100000040000000020000000004000000020000000000004000000200200000040000020000000200000000000000040000000000000000000000000000004200000040003000000000000000000000020000100002000400000001000000000000210000000000000000000001010200000c0000000010000000000000000000000000000000000080480000000000000000000000000080000082000200000000000000000000000000000000080000008000000010000000000000008004000000000000002204030000000000000000000000000000040000800010500000000000020000000000000000000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAABKAAAATwAAAIABBgBgAAAAAQMIACgAAAAD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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T04:08:19Z</structure-indexed-at>
</compound>
